MA55808A - Procédé de préparation d'inhibiteurs de xpo1 et intermédiaires destinés à être utilisés dans la préparation d'inhibiteurs de xpo1 - Google Patents

Procédé de préparation d'inhibiteurs de xpo1 et intermédiaires destinés à être utilisés dans la préparation d'inhibiteurs de xpo1

Info

Publication number
MA55808A
MA55808A MA055808A MA55808A MA55808A MA 55808 A MA55808 A MA 55808A MA 055808 A MA055808 A MA 055808A MA 55808 A MA55808 A MA 55808A MA 55808 A MA55808 A MA 55808A
Authority
MA
Morocco
Prior art keywords
preparing
xpo1 inhibitors
intermediates
xpo1
inhibitors
Prior art date
Application number
MA055808A
Other languages
English (en)
French (fr)
Inventor
Brian Clinton Austad
David G Roe
Original Assignee
Karyopharm Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karyopharm Therapeutics Inc filed Critical Karyopharm Therapeutics Inc
Publication of MA55808A publication Critical patent/MA55808A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA055808A 2019-05-01 2020-05-01 Procédé de préparation d'inhibiteurs de xpo1 et intermédiaires destinés à être utilisés dans la préparation d'inhibiteurs de xpo1 MA55808A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962841649P 2019-05-01 2019-05-01

Publications (1)

Publication Number Publication Date
MA55808A true MA55808A (fr) 2022-03-09

Family

ID=70802955

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055808A MA55808A (fr) 2019-05-01 2020-05-01 Procédé de préparation d'inhibiteurs de xpo1 et intermédiaires destinés à être utilisés dans la préparation d'inhibiteurs de xpo1

Country Status (14)

Country Link
US (1) US12479806B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962898A1 (cg-RX-API-DMAC7.html)
JP (2) JP7630444B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004142A (cg-RX-API-DMAC7.html)
CN (1) CN114040909B (cg-RX-API-DMAC7.html)
AU (1) AU2020266170B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021021706A2 (cg-RX-API-DMAC7.html)
CA (1) CA3135712A1 (cg-RX-API-DMAC7.html)
CR (1) CR20210590A (cg-RX-API-DMAC7.html)
IL (1) IL287673B1 (cg-RX-API-DMAC7.html)
MA (1) MA55808A (cg-RX-API-DMAC7.html)
MX (1) MX2021013211A (cg-RX-API-DMAC7.html)
SG (1) SG11202111993SA (cg-RX-API-DMAC7.html)
WO (1) WO2020223678A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114040909B (zh) 2019-05-01 2025-06-03 卡尔约药物治疗公司 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法
JP2021048976A (ja) * 2019-09-24 2021-04-01 株式会社ユニバーサルエンターテインメント 遊技機
CN112679477B (zh) * 2020-12-17 2021-10-26 佛山奕安赛医药科技有限公司 塞利尼索及其中间体的制备方法
CN116514773B (zh) * 2023-04-24 2024-12-03 重庆汉佩生物科技有限公司 一种Verdinexor(KPT-335)及其盐酸盐的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542089B1 (en) 2010-03-05 2017-01-18 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP2665362B1 (en) 2011-01-17 2016-03-30 Karyopharm Therapeutics, Inc. Olefin containing nuclear transport modulators and uses thereof
EP4234545A3 (en) 2011-07-29 2023-09-06 Karyopharm Therapeutics Inc. Hydrazide containing nuclear transport modulators and uses thereof
JP6006794B2 (ja) 2011-07-29 2016-10-12 カリオファーム セラピューティクス,インコーポレイテッド 核内輸送調節因子およびその使用
WO2013170068A2 (en) * 2012-05-09 2013-11-14 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
WO2014205393A1 (en) 2013-06-21 2014-12-24 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
ME03421B (me) 2013-06-21 2020-01-20 Karyopharm Therapeutics Inc 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
WO2017118940A1 (en) * 2016-01-08 2017-07-13 Dr. Reddy's Laboratories Limited Solid forms of selinexor and process for their preparation
EP3565813A1 (en) * 2017-01-05 2019-11-13 Watson Laboratories, Inc. Novel crystalline forms of selinexor and process for their preparation
CN114040909B (zh) 2019-05-01 2025-06-03 卡尔约药物治疗公司 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法

Also Published As

Publication number Publication date
AU2020266170A1 (en) 2021-11-25
US20220242832A1 (en) 2022-08-04
CR20210590A (es) 2022-03-11
JP2025072490A (ja) 2025-05-09
JP2022531576A (ja) 2022-07-07
JP7850834B2 (ja) 2026-04-23
CA3135712A1 (en) 2020-11-05
WO2020223678A1 (en) 2020-11-05
US12479806B2 (en) 2025-11-25
MX2021013211A (es) 2022-03-11
SG11202111993SA (en) 2021-11-29
IL287673B1 (en) 2026-01-01
EP3962898A1 (en) 2022-03-09
JP7630444B2 (ja) 2025-02-17
CN114040909A (zh) 2022-02-11
IL287673A (en) 2021-12-01
BR112021021706A2 (pt) 2022-04-19
KR20220004142A (ko) 2022-01-11
AU2020266170B2 (en) 2026-02-26
CN114040909B (zh) 2025-06-03

Similar Documents

Publication Publication Date Title
MA55808A (fr) Procédé de préparation d'inhibiteurs de xpo1 et intermédiaires destinés à être utilisés dans la préparation d'inhibiteurs de xpo1
EP3927701A4 (en) PROCESSES FOR THE PREPARATION OF ANTHRANILDIAMIDES AND INTERMEDIATE PRODUCTS THEREOF
EP3858697A4 (en) METHOD AND DEVICE FOR OBSTACLE AVOIDANCE
EP3934285A4 (en) METHOD AND APPARATUS FOR UPDATING SATELLITE TRACKING PLANS
EP3768708A4 (en) METHODS AND CONNECTIONS FOR TARGETED AUTOPHAGY
EP3812890A4 (en) SOFTWARE UPDATE AGENT AND PATCH PROCEDURE USING THE SAME
EP4000601A4 (en) Stable ast-3424 injection preparation and preparation method
EP4036661A4 (en) WEARABLE DEVICE AND INDICATION METHOD
EP4040292A4 (en) PROCEDURES FOR NS INSTANTIZATION AND NFVO
MA55821A (fr) Antagonistes 5-ht2a destinés à être utilisés dans le traitement de la dépression
EP4155502A4 (en) SUPPORTS FOR RISER PIPES AND METHODS FOR COUPLING AND UNCOUPLING
EP3998091A4 (en) TISSUE ENGINEERED MATERIAL FOR REPAIR OF NERVE LESIONS, METHOD OF ITS PREPARATION AND ITS USE
EP3594216A4 (en) FIVE-PIECE HETEROCYCLIC AMINOPYRIMIDINE COMPOUND AND INTERMEDIATE PRODUCT, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
EP3826341A4 (en) METHOD AND DEVICE FOR USE IN REGISTRATION
EP3951813A4 (en) TRANSFORMER AND TRANSFORMER MACHINING PROCESS
MA52691A (fr) Compositions à base de statine et procédés destinés à être utilisés dans le traitement de synucléinopathies
EP4003374A4 (en) COMPOSITION AND METHODS OF ADOPTIVE IMMUNOTHERAPY
EP3878435A4 (en) IRINOTECAN LIPOSOME PREPARATION, MANUFACTURE AND USE THEREOF
EP3814318A4 (en) PRODUCTION PROCESS FOR ESTERQUATS BASED ON OIL
EP3761969A4 (en) COOLING COMPOSITION AND METHOD OF USE
EP3943516A4 (en) CATALYST COMPOSITION AND PROCESS FOR THE PRODUCTION OF POLYISOBUTENE USING THE SAME
EP3977845A4 (en) CULTIVATION SUPPORT DEVICE AND CULTIVATION SUPPORT METHOD
EP3787399A4 (en) DEVICE AND METHOD FOR BREEDING INVERTEBRATES
EP4086036A4 (en) WORKPIECE EXCHANGE DEVICE AND PROCESS
EP4021920A4 (en) IMPROVED PROCESS FOR PRODUCTION OF ETELCALCETIDE HYDROCHLORIDE